Publication:
Trends of COPD in Spain: Changes Between Cross Sectional Surveys 1997, 2007 and 2017.

dc.contributor.authorGarcía Castillo, Elena
dc.contributor.authorAlonso Pérez, Tamara
dc.contributor.authorPeláez, Adrián
dc.contributor.authorPérez González, Patricia
dc.contributor.authorMiravitlles, Marc
dc.contributor.authorAlfageme, Inmaculada
dc.contributor.authorCasanova, Ciro
dc.contributor.authorCosío, Borja G
dc.contributor.authorde Lucas, Pilar
dc.contributor.authorGarcía-Río, Francisco
dc.contributor.authorRodríguez González-Moro, José Miguel
dc.contributor.authorSoler-Cataluña, Juan José
dc.contributor.authorSánchez, Guadalupe
dc.contributor.authorSoriano, Joan B
dc.contributor.authorAncochea, Julio
dc.date.accessioned2025-01-22T13:56:05Z
dc.date.available2025-01-22T13:56:05Z
dc.date.issued2023-03
dc.descriptionIBERPOC study funding was obtained from Boehringer Ingelheim, Spain, S.A. EPISCAN study was a GSKsponsored GlaxoSmithKline Spain. EPISCAN II study was a GSK sponsored study, registered in ClinicalTrials.gov Identifier: NCT01122758.
dc.description.abstractIntroduction: We aim to describe the changes in prevalence and risk factors associated to chronic obstructive pulmonary disease (COPD) in Spain, comparing three population-based studies conducted in three timepoints. Methods: We compared participants from IBERPOC conducted in 1997, EPISCAN conducted in 2007 and EPISCAN II in 2017. COPD was defined as a postbronchodilator FEV1/FVC (forced expiratory volume in 1s/forced vital capacity) ratio <0.70, according to GOLD criteria; subsequently, also as the FEV1/FVC below the lower limit of normal (LLN). Results: COPD prevalence in the population between 40 and 69 years decreased from 21.6% (95% CI 20.7%-23.2%) in 1997 to 8.8% (95% CI 8.2%-9.5%) in 2017, a 59.2% decline (p<0.001). In 2007, the prevalence was 7.7% (95% CI 6.8%-8.7%) with an upward trend of 1.1 percentage points in 2017 (p=0.073). Overall COPD prevalence decreased in men and women, although a significant increase was observed in the last decade in females (p<0.05). Current smokers significantly increased in the last decades (25.4% in 1997, 29.1% in 2007 and 23.4% in 2017; p<0.001). Regrettably, COPD underdiagnosis was constantly high, 77.6% in 1997, 78.4% in 2007, and to 78.2% in 2017 (p=0.95), higher in younger ages (40-49 yrs and 50-59 yrs) and also higher in women than in men in all three studies (p<0.05). Conclusions: We report a significant reduction of 59.2% in the prevalence of COPD in Spain from 1997 to 2017 in subjects aged 40-69 years. Our study highlights the significant underdiagnosis of COPD, particularly sustained in women and younger populations.
dc.description.peerreviewed
dc.format.number(3)
dc.format.page142-151
dc.format.volume59
dc.identifier.citationArch Bronconeumol. 2023 Mar;59(3):142-151.
dc.identifier.journalArchivos de Bronconeumología
dc.identifier.pubmedID36549937
dc.identifier.urihttps://hdl.handle.net/20.500.12105/26099
dc.language.isoeng
dc.publisherElsevier
dc.relation.publisherversionhttps://10.1016/j.arbres.2022.11.014
dc.repisalud.institucionCNIC
dc.repisalud.orgCNICCNIC::Unidades técnicas::Bioinformática
dc.rights.accessRightsopen access
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectCOPD
dc.subjectPrevalence
dc.subjectSmoking
dc.subjectSpain
dc.subjectSpirometry
dc.subjectUnderdiagnosis
dc.titleTrends of COPD in Spain: Changes Between Cross Sectional Surveys 1997, 2007 and 2017.
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Trends of COPD in Spain_Arch Bronconeumol_2023.pdf
Size:
1.93 MB
Format:
Adobe Portable Document Format